# Clair Health

> Women's-health wearable interpreting hormone-related physiological signals; Speedrun SR006, $11M seed.

## Why it is interesting

Clair was featured by Fortune after an $11M seed and a reported 25,000-person waitlist. It is also a case where health-device claims require heightened evidence scrutiny: sensor-model inference is not equivalent to direct clinically validated hormone measurement.

## Profile

- **Latest funding:** Seed — $11M (June 17, 2026)
- **Latest known valuation:** Not publicly disclosed
- **Total disclosed equity funding:** $11M
- **Stage:** seed
- **Status:** private
- **Industries:** N/A
- **Coverage:** full
- **Last updated:** 2026-11-04
- **Latest funding investors:** Khosla Ventures, a16z Speedrun

## Funding history

- Seed · $11M · June 17, 2026
  Source: https://www.fortune.com/2026/06/17/clair-khosla-anne-wojcicki-wearble-oura-whoop-hormone-women-health/

## Related articles

- https://venturecapitaltracker.com/a16z-speedrun-guide

**By:** [Venture Capital Tracker](https://venturecapitaltracker.com/editorial-policy)
**Last updated:** November 4, 2026

**Editorial note:** AI tools assisted with research, structure, or drafting. Venture Capital Tracker retains human editorial responsibility for factual accuracy, relevance, and source quality before publication.

---
Source: https://venturecapitaltracker.com/startup/clair-health-wearable